CX Institutional’s Celgene Corp CELG Stock Holding History

CX Institutional’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-266	Closed	-$26K	–	791
2019 Q3	$26K	Buy	266 +17	+7%	+$1.61K	﹤0.01%	350
2019 Q2	$23K	Buy	249 +28	+13%	+$2.66K	﹤0.01%	395
2019 Q1	$21K	Buy	221 +136	+160%	+$11.9K	﹤0.01%	400
2018 Q4	$5K	Buy	85 +31	+57%	+$2.29K	﹤0.01%	402
2018 Q3	$5K	Hold	54	–	–	﹤0.01%	297
2018 Q2	$4K	Buy	+54	New	+$4.48K	﹤0.01%	288

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

CX Institutional's CELG Position: Q4 2019 in Review

CX Institutional sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 266 shares — an estimated $26K sold.

CX Institutional first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $26K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

CX Institutional reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
CX Institutional sold 266 Celgene Corp shares in Q4 2019, an estimated $26K.
CX Institutional first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
CX Institutional's Celgene Corp position peaked at $26K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on CX Institutional's 13F filing for Q4 2019, filed 21 Jan 2020.